Fowler Neal Franklin has filed 5 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 34403 shares of Emergent BioSolutions Inc. ($EBS) on April 30, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 30, 2025 | Emergent BioSolutions Inc. | $EBS | Fowler Neal Franklin | Director | A | Common Stock | 34403 | $0.00 | 135,503.0000 | 53,000,000 | 34.03% | 0.06% |
| April 30, 2025 | Emergent BioSolutions Inc. | $EBS | Fowler Neal Franklin | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| March 12, 2025 | Emergent BioSolutions Inc. | $EBS | Fowler Neal Franklin | Director | S | Common Stock | 35000 | $5.83 | 101,100.0000 | 53,000,000 | 25.72% | 0.07% |
| May 23, 2024 | Emergent BioSolutions Inc. | $EBS | Fowler Neal Franklin | Director | A | Common Stock | 17430 | $0.00 | 136,100.0000 | 51,200,000 | 14.69% | 0.03% |
| May 23, 2024 | Emergent BioSolutions Inc. | $EBS | Fowler Neal Franklin | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |